Adage Capital Partners Gp, L.L.C. Syros Pharmaceuticals, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $326,000 - $466,000	100,000 Added 5.56%	1,900,000 $6.19 Million
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $3.87 Million - $5.36 Million	947,700 Added 111.19%	1,800,000 $8.05 Million
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $4.27 Million - $6.38 Million	852,300 New	852,300 $4.65 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.